N-[1-(5-ethyl-1,2,4-oxadiazol-3-yl)ethyl]ethene-1-sulfonamide
Structure Info
- Chemspace ID
- CSSB07105605001 (In-Stock Building Blocks)
- IUPAC Name
- N-[1-(5-ethyl-1,2,4-oxadiazol-3-yl)ethyl]ethene-1-sulfonamide
- Mol formula
- C8H13N3O3S
- Mol weight
- 231 Da
- Catalog Number(s)
- BBLS07105605001, BBV-882955133, EN300-54653024, bbls07105605001
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 0.98
- Heavy atoms count
- 15
- Rotatable bond count
- 4
- Number of rings
- 1
- Carbon bond saturation, Fsp3
- 0.5
- Polar surface area (Å)
- 85
- Hydrogen bond acceptors count
- 4
- Hydrogen bond donors count
- 1
![Chemical structure of N-[1-(5-ethyl-1,2,4-oxadiazol-3-yl)ethyl]ethene-1-sulfonamide (C8H13N3O3S) - CSSB07105605001](/st/structure/200/9612f9fc7cd50a26180cc715148973ae/CCc1nc%2528no1%2529C%2528C%2529NS%2528%253DO%2529%2528%253DO%2529C%253DC.png "C8H13N3O3S")
- Zoom the structure
- CSSB07105605001
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 504.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 528.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 551.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 575.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 600.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 1,174.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 1,737.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 2,577.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Substructure Analogs
![Chemical structure of N-[1-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)ethyl]ethene-1-sulfonamide - CSSB21332081552](/st/structure/200/b42999649671ee6f29258cc03c131be8/CC%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNOC%2528%253DN1%2529C1CC1.png)
![Chemical structure of N-{1-[5-(propan-2-yl)-1,2,4-oxadiazol-3-yl]ethyl}ethene-1-sulfonamide - CSSB14912090702](/st/structure/200/e0e0da8d0d2c70928bd52a0e8d6a6a1a/CC%2528C%2529c1nc%2528no1%2529C%2528C%2529NS%2528%253DO%2529%2528%253DO%2529C%253DC.png)
![Chemical structure of N-[1-(5-propyl-1,2,4-oxadiazol-3-yl)ethyl]ethene-1-sulfonamide - CSSB14902456111](/st/structure/200/23af3ad9555cbad7d8f00a6e84c5005f/CCCc1nc%2528no1%2529C%2528C%2529NS%2528%253DO%2529%2528%253DO%2529C%253DC.png)
![Chemical structure of N-[1-(5-tert-butyl-1,2,4-oxadiazol-3-yl)ethyl]ethene-1-sulfonamide - CSSB21332081043](/st/structure/200/662f4c0cc51c72499c85f84adabab69d/CC%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNOC%2528%253DN1%2529C%2528C%2529%2528C%2529C.png)
![Chemical structure of N-[1-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)propyl]ethene-1-sulfonamide - CSSB21332048440](/st/structure/200/4871744e3d11a9022070b5f3ed49173d/CCC%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNOC%2528%253DN1%2529C1CC1.png)
![Chemical structure of N-[cyclopropyl(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]ethene-1-sulfonamide - CSSB21332096142](/st/structure/200/f5ad7aaaa7b4d61a72951be0424f8f0d/CCC1%253DNC%2528%253DNO1%2529C%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1CC1.png)
![Chemical structure of N-{1-[5-(1,1-difluoroethyl)-1,2,4-oxadiazol-3-yl]ethyl}ethene-1-sulfonamide - CSSB21332048167](/st/structure/200/2812b666d2f70fb59b9168b4260174e0/CC%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNOC%2528%253DN1%2529C%2528C%2529%2528F%2529F.png)
Similarity Analogs
![Chemical structure of N-(1-{5-[(propan-2-yloxy)methyl]-1,2,4-oxadiazol-3-yl}ethyl)ethene-1-sulfonamide - CSSB21332116319](/st/structure/200/c06015a48f9f6c0639f6d9d821a9ca57/CC%2528C%2529OCC1%253DNC%2528%253DNO1%2529C%2528C%2529NS%2528%253DO%2529%2528%253DO%2529C%253DC.png)
![Chemical structure of N-{1-[5-(ethoxymethyl)-1,2,4-oxadiazol-3-yl]ethyl}ethene-1-sulfonamide - CSSB06835390633](/st/structure/200/ef038f31b646fbce702ce32cd4f53256/CCOCc1nc%2528no1%2529C%2528C%2529NS%2528%253DO%2529%2528%253DO%2529C%253DC.png)
![Chemical structure of N-[(1R)-1-(5-methyl-1,2,4-oxadiazol-3-yl)ethyl]ethene-1-sulfonamide - CSSB20481155834](/st/structure/200/3715b138ee4d33f22d58afdfeb4b865c/C%255BC%2540%2540H%255D%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNOC%2528C%2529%253DN1.png)
![Chemical structure of N-[1-(5-methyl-1,2,4-oxadiazol-3-yl)ethyl]ethene-1-sulfonamide - CSSB09888515099](/st/structure/200/5e63667116f1e02b21db09b9e6d41a7f/CC%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529c1noc%2528C%2529n1.png)
![Chemical structure of N-[(1S)-1-(5-methyl-1,2,4-oxadiazol-3-yl)ethyl]ethene-1-sulfonamide - CSSB20481151831](/st/structure/200/8fdb5c3bed4e7d3284fc898728f62379/C%255BC%2540H%255D%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNOC%2528C%2529%253DN1.png)
![Chemical structure of N-[1-(5-benzyl-1,2,4-oxadiazol-3-yl)ethyl]ethene-1-sulfonamide - CSSB21332082711](/st/structure/200/f88dfbef03a09cc1257993888b245742/CC%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNOC%2528CC2%253DCC%253DCC%253DC2%2529%253DN1.png)
